Pierre de Zeeuw

Patient Safety Oncology, Novartis, Basel, Switzerland, Switzerland

Novartis (Employment)

Poster(s):

• (P-070) Risk of Thrombotic Microangiopathy with Tyrosine Kinase Inhibitors: A Disproportionality Analysis from Vigibase and AERS Databases